Skip To Main Content
Zhiying He on Muck Rack

Zhiying He

As seen in: Nature, Wiley Online Library, ACS Publications, Dialnet - Universidad de La Rioja
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Zhiying

Contact Zhiying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Molecular imaging-guided discovery of a potent natural FAPα inhibitor for liver fibrosis therapy

|
By Wenze Zhang, Jiwei Li, Lei Sun, Chaoran Li, Kaiyu Zhang, Zhiying He, Guangyi Yang, Boyang Yu, Fengguo Xu, Haijun Xu, Xianchuang Zheng, Jiangwei Tian
| Nature Verified
Abstract Liver fibrosis can progress to cirrhosis and hepatocellular carcinoma, yet effective antifibrotic therapies remain limited. Fibroblast activation protein α (FAPα) is a promising biomarker and therapeutic target, but existing probes are constrained by limited tissue penetration and single-modality imaging, and effective FAPα-targeted antifibrotic agents remain lacking.
Open in Who Shared Issue with article?

PRIME-HFrEF Trial: a randomized, double-blind, multi-dose umbilical cord-derived mesenchymal stem cell regimen for heart failure

|
By Wei Han, Yuheng Jiao, Xin Gong, Hao Hu, Yuanfeng Xin, Jun Zhao, Qi Zhang, Jingwei Pan, Haiyan Wang, Qing Lu, Shuguang Chu, Dihui Cai, Liang Zheng, Wenwen Jia, Zhiying He, Yi Sun, Zhongmin Liu, Sibin Guan, Huangtian Yang
| Nature Verified
Abstract The safety of multi-dose mesenchymal stem cell (MSC) regimens has seldom been systematically investigated. The PRIME-HFrEF (Prospective Randomized Controlled Study of Multiple Intravenous Infusions of Umbilical Cord–derived MSCs in Patients with Heart Failure and Reduced Ejection Fraction) trial was a single-center, randomized, placebo-controlled, investigator-initiated study (ClinicalTrials.gov identifier: NCT04992832) that enrolled 40 patients.
Open in Who Shared Issue with article?

Self-Adaptive Superionic Electrolytes via Multiple-Cation Modulation for All-Solid-State Lithium–Metal Batteries Click to copy article link Article link copied!

|
By Zhiying He, Tao Yu, Lixin Liang
| ACS Publications
Abstract Click to copy section linkSection link copied! All-solid-state lithium–metal batteries offer devices with high specific energy and intrinsic safety, yet their practical implementation is impeded by interfacial instability at the lithium metal/electrolyte interface, especially under high current densities.
Open in Who Shared Issue with article?
See all 11 articles